Trial Profile
A prospective trial of the effect of adjuvant trastuzumab treatment in patients with small node negative her2+ breast cancer
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 25 Jul 2014
Price :
$35
*
At a glance
- Drugs Trastuzumab (Primary)
- Indications Breast cancer
- Focus Adverse reactions; Therapeutic Use
- 25 Jul 2014 New trial record
- 03 Jun 2014 Baseline demographics presented at the 50th Annual Meeting of the American Society Clinical Oncology
- 01 Mar 2013 Status changed to active, no longer recruiting as per 50th Annual Meeting of the American Society Clinical Oncology